메뉴 건너뛰기




Volumn 56, Issue 5, 2001, Pages 467-472

Smoking cessation: The role of bupropion among new pharmacologic agents

Author keywords

Antidepressant; Bupropion; Nicotine replacement therapy; Smoking cessation

Indexed keywords

AMFEBUTAMONE; ANTIARRHYTHMIC AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUSPIRONE; CARBAMAZEPINE; CLONIDINE; DIAZEPAM; DOXEPIN; FLUOXETINE; IMIPRAMINE; LOBELINE; MEPROBAMATE; METOPROLOL; MOCLOBEMIDE; MOXONIDINE; NEUROLEPTIC AGENT; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR BLOCKING AGENT; NORTRIPTYLINE; ONDANSETRON; OXPRENOLOL; PHENOBARBITAL; PHENYTOIN; PLACEBO; SEROTONIN ANTAGONIST; TRYPTOPHAN; UNINDEXED DRUG;

EID: 14244271346     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (5)

References (21)
  • 11
    • 0003617863 scopus 로고    scopus 로고
    • US Dept of Health and Human Services: Public Health Service. Treating tobacco use and dependence: Clinical practice guideline
    • AHRQ Publication N° 00-0032, June
    • (2000)
    • Fiore, M.C.1    Bailey, W.C.2    Cohen, S.J.3
  • 15
    • 0001178620 scopus 로고    scopus 로고
    • Evaluation of bupropion versus placebo for treatment of nicotine dependence
    • New Research programme and abstract of the 147th annual meeting of the American Psychiatric Association, May 26, 1994
    • Ferry, L.1    Burchette, R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.